Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators ; volume:13 ; number:1 ; day:19 ; month:6 ; year:2023 ; pages:1-19 ; date:12.2023
Scientific reports ; 13, Heft 1 (19.6.2023), 1-19, 12.2023
- Urheber
-
Kumbhar, Navanath
Nimal, Snehal
Patil, Deeksha
Kaiser, V. Florian
Haupt, Joachim
Gacche, Rajesh N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-36872-0
- URN
-
urn:nbn:de:101:1-2023092208431300482388
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumbhar, Navanath
- Nimal, Snehal
- Patil, Deeksha
- Kaiser, V. Florian
- Haupt, Joachim
- Gacche, Rajesh N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing against COVID-19: focus on anticancer agents
Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs
Repurposing metformin as a potential anticancer agent using in silico technique
Wnt/beta-catenin pathway: modulating anticancer immune response
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer
Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression
Drug repurposing
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing against COVID-19: focus on anticancer agents
Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs
Repurposing metformin as a potential anticancer agent using in silico technique
Wnt/beta-catenin pathway: modulating anticancer immune response
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer
Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression
Drug repurposing
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing against COVID-19: focus on anticancer agents
Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs
Repurposing metformin as a potential anticancer agent using in silico technique
Wnt/beta-catenin pathway: modulating anticancer immune response
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer
Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression
Drug repurposing
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents